Gilead Sciences - 32 Year Stock Price History | GILD

Historical daily share price chart and data for Gilead Sciences since 1992 adjusted for splits and dividends. The latest closing stock price for Gilead Sciences as of April 12, 2024 is 68.07.
  • The all-time high Gilead Sciences stock closing price was 90.21 on June 23, 2015.
  • The Gilead Sciences 52-week high stock price is 87.86, which is 29.1% above the current share price.
  • The Gilead Sciences 52-week low stock price is 67.62, which is 0.7% below the current share price.
  • The average Gilead Sciences stock price for the last 52 weeks is 77.32.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
Gilead Sciences Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2024 75.3517 82.3852 86.3936 68.0700 68.0700 -15.10%
2023 76.8056 81.3854 83.9492 71.8194 80.1781 -2.01%
2022 62.4721 66.1726 84.5756 52.8068 81.8238 23.60%
2021 60.2792 52.5558 67.1390 52.4596 66.1999 29.96%
2020 58.7266 54.7601 71.2166 49.5306 50.9383 -6.62%
2019 53.9645 51.2840 57.1638 50.5012 54.5503 7.88%
2018 58.5716 58.0607 69.5788 48.9397 50.5646 -9.92%
2017 55.7863 56.4534 66.0868 49.1851 56.1332 2.97%
2016 62.7395 72.9382 76.4852 54.2855 54.5122 -27.61%
2015 78.6170 69.7997 90.2054 69.7997 75.3047 8.63%
2014 65.8789 55.3117 84.0008 48.1560 69.3217 25.51%
2013 41.2286 27.6007 55.3044 27.5602 55.2308 104.49%
2012 20.7836 15.3926 28.0714 15.3926 27.0087 79.45%
2011 14.6821 13.4510 15.8890 12.9951 15.0506 12.94%
2010 14.4403 15.9221 18.1835 11.7044 13.3260 -16.25%
2009 16.9573 19.1874 19.4154 15.2381 15.9110 -15.39%
2008 18.0859 16.6722 20.9965 13.7783 18.8050 11.15%
2007 14.5541 11.6106 17.5547 11.5334 16.9186 41.72%
2006 11.3827 10.0570 12.8241 9.8823 11.9379 23.51%
2005 7.7727 6.3854 10.2280 5.7069 9.6654 50.24%
2004 5.9154 5.3337 7.1778 4.7582 6.4332 20.08%
2003 4.7332 3.2074 6.4341 2.9693 5.3576 71.41%
2002 3.1307 2.8236 3.6505 2.4407 3.1256 3.47%
2001 2.3048 1.7037 3.3191 1.2424 3.0208 58.48%
2000 1.7315 1.2941 2.6705 0.9983 1.9061 53.22%
1999 1.2268 0.9135 2.1231 0.8216 1.2440 31.84%
1998 0.7330 0.8763 0.9940 0.4194 0.9436 7.34%
1997 0.7205 0.5631 1.0602 0.4971 0.8791 52.99%
1996 0.6517 0.7497 0.9365 0.3964 0.5746 -21.87%
1995 0.4237 0.2155 0.7412 0.2155 0.7354 236.88%
1994 0.2312 0.2758 0.3218 0.1609 0.2183 -20.85%
1993 0.3400 0.4194 0.4396 0.2471 0.2758 -37.66%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $84.752B $27.116B
Gilead Sciences is a pioneer in developing drugs for the treatment of human immunodeficiency virus, liver diseases, hematology/oncology diseases and inflammation/respiratory diseases. The company has a strong HIV franchise with key HIV/AIDS therapies like tenofovir alafenamide based products - Genvoya, Odefsey, Descovy, Biktarvy and Truvada. The portfolio also includes hepatitis C virus drugs like Harvoni and Epclusa and HBV drug. The first cell therapy approved for the treatment of adult patients with relapsed or refractory large B-cell lymphoma, has diversified Gilead's portfolio. Tecartus, another CAR T-cell therapy, was granted an accelerated approval in the United States for the treatment of relapsed or refractory mantle cell lymphoma. The company is also working on diversifying and growing its business beyond antivirals into other therapeutic areas. Gilead is also making inroads in the oncology space with strategic collaborations and acquisitions.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $143.240B 14.33
Vertex Pharmaceuticals (VRTX) United States $102.492B 29.50
Regeneron Pharmaceuticals (REGN) United States $99.302B 24.07
Bristol Myers Squibb (BMY) United States $97.852B 6.44
CSL (CSLLY) Australia $88.445B 0.00
GSK (GSK) United Kingdom $84.265B 10.56
Moderna (MRNA) United States $40.256B 0.00
Biogen (BIIB) United States $28.808B 13.45
Argenex SE (ARGX) Netherlands $22.417B 0.00
BioNTech SE (BNTX) Germany $20.559B 20.99
Illumina (ILMN) United States $20.237B 146.06
Genmab (GMAB) Denmark $19.348B 24.80
Alnylam Pharmaceuticals (ALNY) United States $18.703B 0.00
BioMarin Pharmaceutical (BMRN) United States $17.405B 73.78
BeiGene (BGNE) Cayman Islands $13.514B 0.00
Exact Sciences (EXAS) United States $12.950B 0.00
Incyte (INCY) United States $12.091B 20.09
Sarepta Therapeutics (SRPT) United States $11.537B 0.00
Bio-Techne Corp (TECH) United States $10.489B 39.02
Bio-Rad Laboratories (BIO.B) United States $9.655B 28.76
Legend Biotech (LEGN) United States $9.627B 0.00
Repligen (RGEN) United States $9.578B 99.15
QIAGEN (QGEN) Netherlands $9.169B 18.98
Roivant Sciences (ROIV) United Kingdom $8.816B 0.00
Ascendis Pharma (ASND) Denmark $8.503B 0.00
Viking Therapeutics (VKTX) United States $7.563B 0.00
Cytokinetics (CYTK) United States $7.483B 0.00
Exelixis (EXEL) United States $6.916B 35.64
Vaxcyte (PCVX) United States $6.708B 0.00
Intra-Cellular Therapies (ITCI) United States $6.378B 0.00
Apellis Pharmaceuticals (APLS) United States $6.245B 0.00
Blueprint Medicines (BPMC) United States $5.340B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $5.150B 0.00
Krystal Biotech (KRYS) United States $4.951B 0.00
Halozyme Therapeutics (HALO) United States $4.906B 15.14
Biohaven (BHVN) United States $4.331B 0.00
Zealand Pharma (ZLDPF) Denmark $4.276B 0.00
Immunovant (IMVT) United States $4.264B 0.00
Nuvalent (NUVL) United States $4.197B 0.00
Alkermes (ALKS) Ireland $4.131B 21.80
Insmed (INSM) United States $4.048B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.868B 0.00
Fortrea Holdings (FTRE) United States $3.490B 0.00
ImmunityBio (IBRX) United States $3.459B 0.00
Iovance Biotherapeutics (IOVA) United States $3.452B 0.00
Axsome Therapeutics (AXSM) United States $3.276B 0.00
Apogee Therapeutics (APGE) United States $3.217B 0.00
Amicus Therapeutics (FOLD) United States $3.155B 0.00
SpringWorks Therapeutics (SWTX) United States $3.154B 0.00
IDEAYA Biosciences (IDYA) United States $3.129B 0.00
HUTCHMED (China) (HCM) Hong Kong, SAR China $3.116B 0.00
Xenon Pharmaceuticals (XENE) Canada $3.115B 0.00
Arcellx (ACLX) United States $3.095B 0.00
Certara (CERT) United States $2.831B 60.93
ACADIA Pharmaceuticals (ACAD) United States $2.824B 0.00
Immunocore Holdings (IMCR) United Kingdom $2.816B 0.00
MoonLake Immunotherapeutics (MLTX) Switzerland $2.805B 0.00
MorphoSys AG (MOR) Germany $2.720B 0.00
Janux Therapeutics (JANX) United States $2.720B 0.00
CG Oncology (CGON) United States $2.649B 0.00
Vera Therapeutics (VERA) United States $2.612B 0.00
Denali Therapeutics (DNLI) United States $2.541B 0.00
Arvinas (ARVN) United States $2.471B 0.00
Merus (MRUS) Netherlands $2.456B 0.00
Rhythm Pharmaceuticals (RYTM) United States $2.425B 0.00
Intellia Therapeutics (NTLA) United States $2.333B 0.00
Vericel (VCEL) United States $2.317B 0.00
Guardant Health (GH) United States $2.222B 0.00
Celldex Therapeutics (CLDX) United States $2.194B 0.00
Rocket Pharmaceuticals (RCKT) United States $2.189B 0.00
Kymera Therapeutics (KYMR) United States $2.174B 0.00
Ginkgo Bioworks Holdings (DNA) United States $2.174B 0.00
Neumora Therapeutics (NMRA) United States $2.155B 0.00
Beam Therapeutics (BEAM) United States $2.117B 0.00
Keros Therapeutics (KROS) United States $2.109B 0.00
Galapagos (GLPG) Belgium $1.993B 0.00
Geron (GERN) United States $1.991B 0.00
Sana Biotechnology (SANA) United States $1.975B 0.00
Avidity Biosciences (RNA) United States $1.920B 0.00
Syndax Pharmaceuticals (SNDX) United States $1.845B 0.00
Structure Therapeutics (GPCR) United States $1.832B 0.00
NeoGenomics (NEO) United States $1.799B 0.00
Twist Bioscience (TWST) United States $1.774B 0.00
Myriad Genetics (MYGN) United States $1.757B 0.00
Bavarian Nordic (BVNRY) Denmark $1.703B 5.59
Harmony Biosciences Holdings (HRMY) United States $1.675B 13.91
Inhibrx (INBX) United States $1.658B 0.00
Protagonist Therapeutics (PTGX) United States $1.576B 0.00
Dynavax Technologies (DVAX) United States $1.549B 0.00
Edgewise Therapeutics (EWTX) United States $1.524B 0.00
Arcus Biosciences (RCUS) United States $1.507B 0.00
Kura Oncology (KURA) United States $1.483B 0.00
Ligand Pharmaceuticals (LGND) United States $1.441B 17.84
Gyre Therapeutics (GYRE) United States $1.436B 0.00
Morphic Holding (MORF) United States $1.434B 0.00
Zai Lab (ZLAB) China $1.420B 0.00
ANI Pharmaceuticals (ANIP) United States $1.410B 17.33
ADMA Biologics Inc (ADMA) United States $1.374B 0.00
Autolus Therapeutics (AUTL) United Kingdom $1.335B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $1.286B 0.00
AbCellera Biologics (ABCL) Canada $1.271B 0.00
Akero Therapeutics (AKRO) United States $1.249B 0.00
Tarsus Pharmaceuticals (TARS) United States $1.238B 0.00
Immunome (IMNM) United States $1.229B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $1.221B 0.00
Deciphera Pharmaceuticals (DCPH) United States $1.216B 0.00
Vir Biotechnology (VIR) United States $1.206B 0.00
Day One Biopharmaceuticals (DAWN) United States $1.203B 0.00
Prothena (PRTA) Ireland $1.195B 0.00
Mirum Pharmaceuticals (MIRM) United States $1.155B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $1.153B 0.00
MannKind (MNKD) United States $1.123B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $1.119B 0.00
Belite Bio (BLTE) United States $1.076B 0.00
Liquidia Technologies (LQDA) United States $1.061B 0.00
Scholar Rock Holding (SRRK) United States $1.047B 0.00
Viridian Therapeutics (VRDN) United States $0.997B 0.00
Arcutis Biotherapeutics (ARQT) United States $0.988B 0.00
Kyverna Therapeutics (KYTX) United States $0.982B 0.00
Zentalis Pharmaceuticals (ZNTL) United States $0.952B 0.00
MiMedx (MDXG) United States $0.946B 214.67
Abivax SA (ABVX) France $0.944B 0.00
89BIO (ETNB) United States $0.918B 0.00
Immatics (IMTX) Germany $0.898B 0.00
REGENXBIO (RGNX) United States $0.887B 0.00
Pliant Therapeutics (PLRX) United States $0.852B 0.00
Nurix Therapeutics (NRIX) United States $0.823B 0.00
Cabaletta Bio (CABA) United States $0.822B 0.00
CARGO Therapeutics (CRGX) United States $0.820B 0.00
Arcturus Therapeutics Holdings (ARCT) United States $0.819B 0.00
Cytek Biosciences (CTKB) United States $0.807B 0.00
Tango Therapeutics (TNGX) United States $0.785B 0.00
Tyra Biosciences (TYRA) United States $0.782B 0.00
Disc Medicine (IRON) United States $0.768B 0.00
Dianthus Therapeutics (DNTH) United States $0.760B 0.00
HilleVax (HLVX) United States $0.747B 0.00
Praxis Precision Medicines (PRAX) United States $0.730B 0.00
PureTech Health (PRTC) United States $0.730B 0.00
Cullinan Oncology (CGEM) United States $0.718B 0.00
WAVE Life Sciences (WVE) Singapore $0.709B 0.00
Pharming Group (PHAR) Netherlands $0.707B 0.00
Aerovate Therapeutics (AVTE) United States $0.703B 0.00
Pharming Group (PHGUF) Netherlands $0.695B 0.00
Longboard Pharmaceuticals (LBPH) United States $0.692B 0.00
Prime Medicine (PRME) United States $0.687B 0.00
Mind Medicine (MindMed) (MNMD) United States $0.679B 0.00
EnGene Holdings (ENGN) United States $0.671B 0.00
Bicycle Therapeutics (BCYC) United Kingdom $0.670B 0.00
Oric Pharmaceuticals (ORIC) United States $0.660B 0.00
Absci (ABSI) United States $0.658B 0.00
ALX Oncology Holdings (ALXO) United States $0.653B 0.00
Zymeworks (ZYME) United States $0.653B 0.00
CureVac (CVAC) Germany $0.651B 0.00
Nuvation Bio (NUVB) United States $0.648B 0.00
Mineralys Therapeutics (MLYS) United States $0.646B 0.00
Allogene Therapeutics (ALLO) United States $0.643B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.629B 0.00
Northwest Biotherapeutics (NWBO) United States $0.625B 0.00
Cogent Biosciences (COGT) United States $0.622B 0.00
Mesoblast (MESO) Australia $0.613B 0.00
AnaptysBio (ANAB) United States $0.608B 0.00
Olema Pharmaceuticals (OLMA) United States $0.607B 0.00
Novavax (NVAX) United States $0.599B 0.00
Astria Therapeutics (ATXS) United States $0.594B 0.00
Phathom Pharmaceuticals (PHAT) United States $0.593B 0.00
Stoke Therapeutics (STOK) United States $0.591B 0.00
GH Research (GHRS) Ireland $0.582B 0.00
Alector (ALEC) United States $0.576B 0.00
Fate Therapeutics (FATE) United States $0.573B 0.00
ArriVent BioPharma (AVBP) United States $0.566B 0.00
Celcuity (CELC) United States $0.558B 0.00
Castle Biosciences (CSTL) United States $0.551B 0.00
Applied Therapeutics (APLT) United States $0.546B 0.00
IGM Biosciences (IGMS) United States $0.538B 0.00
Annexon (ANNX) United States $0.538B 0.00
ACELYRIN, INC (SLRN) United States $0.528B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.527B 0.00
Arbutus Biopharma (ABUS) United States $0.522B 0.00
Neurogene (NGNE) United States $0.510B 0.00
C4 Therapeutics (CCCC) United States $0.508B 0.00
Editas Medicine (EDIT) United States $0.508B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.485B 0.00
Travere Therapeutics (TVTX) United States $0.485B 0.00
Oculis Holding AG (OCS) Switzerland $0.484B 0.00
Third Harmonic Bio (THRD) United States $0.469B 0.00
Biomea Fusion (BMEA) United States $0.466B 0.00
Fulcrum Therapeutics (FULC) United States $0.465B 0.00
Mersana Therapeutics (MRSN) United States $0.462B 0.00
Voyager Therapeutics (VYGR) United States $0.458B 2.73
Shattuck Labs (STTK) United States $0.443B 0.00
Ocugen (OCGN) United States $0.439B 0.00
Replimune (REPL) United States $0.438B 0.00
Adaptive Biotechnologies (ADPT) United States $0.437B 0.00
Entrada Therapeutics (TRDA) United States $0.435B 0.00
Nkarta (NKTX) United States $0.432B 0.00
Revance Therapeutics (RVNC) United States $0.430B 0.00
Avid Bioservices (CDMO) United States $0.426B 0.00
PepGen (PEPG) United States $0.421B 0.00
ITeos Therapeutics (ITOS) United States $0.420B 0.00
MaxCyte (MXCT) United States $0.418B 0.00
Jasper Therapeutics (JSPR) United States $0.418B 0.00
Amarin (AMRN) Ireland $0.393B 0.00
Solid Biosciences (SLDB) United States $0.392B 0.00
Adlai Nortye (ANL) Cayman Islands $0.390B 0.00
Alto Neuroscience (ANRO) United States $0.384B 0.00
Caribou Biosciences (CRBU) United States $0.379B 0.00
Aura Biosciences (AURA) United States $0.373B 0.00
Anika Therapeutics (ANIK) United States $0.371B 0.00
TScan Therapeutics (TCRX) United States $0.371B 0.00
ADC Therapeutics SA (ADCT) Switzerland $0.362B 0.00
Monte Rosa Therapeutics (GLUE) United States $0.362B 0.00
MeiraGTx Holdings (MGTX) United States $0.357B 0.00
Urogen Pharma (URGN) United States $0.354B 0.00
Precigen (PGEN) United States $0.353B 0.00
Anavex Life Sciences (AVXL) United States $0.353B 0.00
Invivyd (IVVD) United States $0.352B 0.00
Tenaya Therapeutics (TNYA) United States $0.350B 0.00
FibroBiologics (FBLG) United States $0.349B 0.00
Humacyte (HUMA) United States $0.343B 0.00
MEREO BIOPHARMA (MREO) United Kingdom $0.340B 0.00
Terns Pharmaceuticals (TERN) United States $0.332B 0.00
Ventyx Biosciences (VTYX) United States $0.324B 0.00
CorMedix Inc (CRMD) United States $0.320B 0.00
Rapt Therapeutics (RAPT) United States $0.320B 0.00
Erasca (ERAS) United States $0.320B 0.00
Inozyme Pharma (INZY) United States $0.318B 0.00
Atea Pharmaceuticals (AVIR) United States $0.316B 0.00
Nautilus Biotechnology (NAUT) United States $0.309B 0.00
XOMA (XOMA) United States $0.301B 0.00
Kamada (KMDA) Israel $0.295B 22.35
ChromaDex (CDXC) United States $0.290B 0.00
Verastem (VSTM) United States $0.286B 0.00
Contineum Therapeutics (CTNM) $0.283B 0.00
XBiotech (XBIT) United States $0.282B 0.00
AC Immune (ACIU) Switzerland $0.271B 0.00
Rani Therapeutics Holdings (RANI) United States $0.271B 0.00
Poseida Therapeutics (PSTX) United States $0.263B 0.00
2seventy Bio (TSVT) United States $0.259B 0.00
Sutro Biopharma (STRO) United States $0.259B 0.00
Inovio Pharmaceuticals (INO) United States $0.258B 0.00
Puma Biotechnology (PBYI) United States $0.254B 11.46
Oxford BioMedica (OXBDF) United Kingdom $0.252B 0.00
Coherus BioSciences (CHRS) United States $0.251B 0.00
Cardiff Oncology (CRDF) United States $0.251B 0.00
Adverum Biotechnologies (ADVM) United States $0.243B 0.00
G1 Therapeutics (GTHX) United States $0.238B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.237B 82.40
Kodiak Sciences (KOD) United States $0.232B 0.00
Elevation Oncology (ELEV) United States $0.230B 0.00
UniQure (QURE) Netherlands $0.229B 0.00
Ovid Therapeutics (OVID) United States $0.226B 0.00
X4 Pharmaceuticals (XFOR) United States $0.225B 0.00
Acumen Pharmaceuticals (ABOS) United States $0.225B 0.00
Compass Therapeutics (CMPX) United States $0.223B 0.00
Opthea (OPT) Australia $0.222B 0.00
Scilex Holding (SCLX) United States $0.221B 0.00
Prima BioMed (IMMP) Australia $0.219B 0.00
23andMe Holding (ME) United States $0.214B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.213B 0.00
Design Therapeutics (DSGN) United States $0.208B 0.00
BioStem Technologies (BSEM) $0.207B 0.00
Abeona Therapeutics (ABEO) United States $0.207B 0.00
Akoya Biosciences (AKYA) United States $0.203B 0.00
Gossamer Bio (GOSS) United States $0.202B 0.00
Codexis (CDXS) United States $0.202B 0.00
Trevi Therapeutics (TRVI) United States $0.201B 0.00
Greenwich LifeSciences (GLSI) United States $0.201B 0.00
Innate Pharma S.A (IPHA) France $0.201B 0.00
Werewolf Therapeutics (HOWL) United States $0.200B 0.00
Candel Therapeutics (CADL) United States $0.195B 0.00
INmune Bio (INMB) United States $0.187B 0.00
Inventiva S.A (IVA) France $0.186B 0.00
Compugen (CGEN) Israel $0.185B 0.00
Alimera Sciences (ALIM) United States $0.184B 0.00
Lifecore Biomedical (LFCR) United States $0.184B 0.00
LENZ Therapeutics (LENZ) United States $0.182B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.179B 0.00
GENFIT S.A (GNFT) France $0.178B 0.00
ScPharmaceuticals (SCPH) United States $0.178B 0.00
Adicet Bio (ACET) United States $0.177B 0.00
Orchestra BioMed Holdings (OBIO) United States $0.175B 0.00
Agenus (AGEN) United States $0.171B 0.00
Skye Bioscience (SKYE) United States $0.159B 0.00
Renovaro (RENB) United States $0.157B 0.00
CervoMed (CRVO) United States $0.155B 0.00
Sagimet Biosciences (SGMT) United States $0.154B 0.00
Spyre Therapeutics (SYRE) United States $0.152B 0.00
BioAtla (BCAB) United States $0.151B 0.00
Cellectis S.A (CLLS) France $0.150B 0.00
Omega Therapeutics (OMGA) United States $0.148B 0.00
I-Mab (IMAB) China $0.146B 0.00
CytomX Therapeutics (CTMX) United States $0.146B 0.00
Zura Bio (ZURA) United States $0.145B 0.00
Molecular Partners AG (MOLN) Switzerland $0.144B 0.00
Syros Pharmaceuticals (SYRS) United States $0.143B 0.00
Repare Therapeutics (RPTX) Canada $0.135B 0.00
DBV Technologies S.A (DBVT) France $0.134B 0.00
VistaGen Therapeutics (VTGN) United States $0.132B 0.00
Coya Therapeutics (COYA) United States $0.132B 0.00
Vor Biopharma (VOR) $0.130B 0.00
Immunic (IMUX) United States $0.130B 0.00
Annovis Bio (ANVS) United States $0.128B 0.00
Nuvectis Pharma (NVCT) United States $0.125B 0.00
Barinthus Biotherapeutics (BRNS) United Kingdom $0.122B 0.00
TELA Bio (TELA) United States $0.121B 0.00
Bluebird Bio (BLUE) United States $0.120B 0.00
Seer (SEER) United States $0.119B 0.00
Vigil Neuroscience (VIGL) United States $0.119B 0.00
ATyr Pharma (LIFE) United States $0.118B 0.00
PDS Biotechnology (PDSB) United States $0.117B 0.00
Adagene (ADAG) China $0.117B 0.00
Oncobiologics (OTLK) United States $0.113B 0.00
Genelux (GNLX) United States $0.111B 0.00
Emergent Biosolutions (EBS) United States $0.108B 0.00
Rezolute (RZLT) United States $0.107B 0.00
BioHarvest Sciences (CNVCF) Canada $0.107B 0.00
Cartesian Therapeutics (RNAC) United States $0.105B 0.00
IO Biotech (IOBT) Denmark $0.102B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.101B 0.00
Elicio Therapeutics (ELTX) United States $0.101B 0.00
Seres Therapeutics (MCRB) United States $0.099B 0.00
Alpha Teknova (TKNO) United States $0.098B 0.00
Precision BioSciences (DTIL) United States $0.098B 0.00
Allakos (ALLK) United States $0.098B 0.00
Sangamo Therapeutics (SGMO) United States $0.097B 0.00
Connect Biopharma Holdings (CNTB) United States $0.095B 0.00
Athira Pharma (ATHA) United States $0.094B 0.00
Clearside Biomedical (CLSD) United States $0.093B 0.00
Q32 Bio (QTTB) United States $0.093B 0.00
DiaMedica Therapeutics (DMAC) United States $0.092B 0.00
Milestone Pharmaceuticals (MIST) Canada $0.092B 0.00
Curis (CRIS) United States $0.090B 0.00
BioXcel Therapeutics (BTAI) United States $0.089B 0.00
Spero Therapeutics (SPRO) United States $0.088B 3.28
InflaRx (IFRX) Germany $0.088B 0.00
Eton Pharmaceuticals (ETON) United States $0.088B 0.00
Affimed (AFMD) Germany $0.088B 0.00
Oncolytics Biotech (ONCY) Canada $0.086B 0.00
Entera Bio (ENTX) Israel $0.086B 0.00
Cue Biopharma (CUE) United States $0.085B 0.00
Atara Biotherapeutics (ATRA) United States $0.085B 0.00
Rallybio (RLYB) United States $0.083B 0.00
Leap Therapeutics (LPTX) United States $0.083B 0.00
Passage Bio (PASG) United States $0.083B 0.00
Gritstone Bio (GRTS) United States $0.082B 0.00
AN2 Therapeutics (ANTX) United States $0.082B 0.00
BeyondSpring (BYSI) United States $0.081B 0.00
YS Biopharma (YS) China $0.080B 0.00
Celularity (CELU) United States $0.080B 0.00
HOOKIPA Pharma (HOOK) United States $0.078B 0.00
MediciNova (MNOV) United States $0.077B 0.00
Cognition Therapeutics (CGTX) United States $0.076B 0.00
Ocean Biomedical (OCEA) United States $0.076B 0.00
Aligos Therapeutics (ALGS) United States $0.076B 0.00
Galena Biopharma (SLS) United States $0.075B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.075B 0.00
Anebulo Pharmaceuticals (ANEB) United States $0.074B 0.00
Eupraxia Pharmaceuticals (EPRX) $0.074B 0.00
VTv Therapeutics (VTVT) United States $0.074B 0.00
Turnstone Biologics (TSBX) United States $0.074B 0.00
Cidara Therapeutics (CDTX) United States $0.073B 0.00
Immix Biopharma (IMMX) United States $0.073B 0.00
Elutia (ELUT) United States $0.073B 0.00
Instil Bio (TIL) United States $0.071B 0.00
Provectus Biopharmaceuticals (PVCT) United States $0.070B 0.00
Lantern Pharma (LTRN) United States $0.069B 0.00
Kronos Bio (KRON) United States $0.068B 0.00
Landos Biopharma (LABP) United States $0.067B 0.00
Equillium (EQ) United States $0.065B 0.00
Ikena Oncology (IKNA) United States $0.064B 0.00
HCW Biologics (HCWB) United States $0.064B 0.00
Checkpoint Therapeutics (CKPT) United States $0.064B 0.00
Genenta Science S.p.A (GNTA) Italy $0.063B 0.00
Intensity Therapeutics (INTS) United States $0.063B 0.00
Kezar Life Sciences (KZR) United States $0.063B 0.00
Vaxxinity (VAXX) United States $0.062B 0.00
Immuneering (IMRX) United States $0.061B 0.00
CollPlant Biotechnologies (CLGN) Israel $0.060B 0.00
Enzo Biochem (ENZ) United States $0.060B 0.00
AVROBIO (AVRO) United States $0.057B 0.00
NextCure (NXTC) United States $0.054B 0.00
Bionano Genomics (BNGO) United States $0.053B 0.00
Beyond Air (XAIR) United States $0.052B 0.00
Dyadic (DYAI) United States $0.051B 0.00
Apollomics (APLM) United States $0.050B 0.00
Regencell Bioscience Holdings (RGC) Hong Kong, SAR China $0.050B 0.00
Carmell (CTCX) United States $0.049B 0.00
Aadi Bioscience (AADI) United States $0.048B 0.00
CalciMedica (CALC) United States $0.048B 0.00
Dare Bioscience (DARE) United States $0.047B 0.00
ARCA Biopharma (ABIO) United States $0.047B 0.00
Clene (CLNN) United States $0.046B 0.00
Bolt Biotherapeutics (BOLT) United States $0.046B 0.00
Ocuphire Pharma (OCUP) United States $0.046B 0.00
Promis Neurosciences (PMN) Canada $0.044B 0.00
SAB Biotherapeutics (SABS) United States $0.043B 0.00
Eledon Pharmaceuticals (ELDN) United States $0.042B 0.00
Cara Therapeutics (CARA) United States $0.042B 0.00
Estrella Immunopharma (ESLA) United States $0.041B 0.00
Quince Therapeutics (QNCX) United States $0.041B 0.00
Xilio Therapeutics (XLO) United States $0.041B 0.00
OKYO Pharma (OKYO) $0.040B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.040B 0.00
BRIACELL THERAP (BCTX) Canada $0.040B 0.00
Semper Paratus Acquisition (TVGN) United States $0.039B 0.00
Cyclo Therapeutics (CYTH) United States $0.036B 0.00
IN8bio (INAB) United States $0.036B 0.00
Fortress Biotech (FBIO) United States $0.035B 0.00
Theratechnologies (THTX) Canada $0.034B 0.00
MiNK Therapeutics (INKT) United States $0.034B 0.00
Prenetics Global (PRE) Cayman Islands $0.034B 0.00
Achilles Therapeutics (ACHL) United Kingdom $0.034B 0.00
Aprea Therapeutics (APRE) United States $0.031B 0.00
Evogene (EVGN) Israel $0.031B 0.00
Spruce Biosciences (SPRB) United States $0.030B 0.00
Aileron Therapeutics (ALRN) United States $0.030B 0.00
Pluri (PLUR) Israel $0.030B 0.00
Femasys (FEMY) United States $0.029B 0.00
Acurx Pharmaceuticals (ACXP) United States $0.028B 0.00
Lexaria Bioscience (LEXX) Canada $0.027B 0.00
BioAffinity Technologies (BIAF) United States $0.027B 0.00
Sensei Biotherapeutics (SNSE) United States $0.026B 0.00
Forte Biosciences (FBRX) United States $0.026B 0.00
NKGen Biotech (NKGN) United States $0.026B 0.00
UNITY Biotechnology (UBX) United States $0.026B 0.00
Eyenovia (EYEN) United States $0.025B 0.00
Lisata Therapeutics (LSTA) United States $0.024B 0.00
Biora Therapeutics (BIOR) United States $0.024B 0.00
Cardio Diagnostics Holdings (CDIO) United States $0.024B 0.00
CytoMed Therapeutics (GDTC) Singapore $0.023B 0.00
NeuroSense Therapeutics (NRSN) Israel $0.022B 0.00
Lumos Pharma (LUMO) United States $0.021B 0.00
Aptose Biosciences (APTO) Canada $0.021B 0.00
Evaxion Biotech (EVAX) Denmark $0.021B 0.00
Vincerx Pharma (VINC) United States $0.021B 0.00
Synlogic (SYBX) United States $0.021B 0.00
RenovoRx (RNXT) United States $0.021B 0.00
KALA BIO (KALA) United States $0.020B 0.00
Galecto (GLTO) Denmark $0.018B 0.00
NeuroBo Pharmaceuticals (NRBO) United States $0.018B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.017B 0.00
Aytu BioPharma (AYTU) United States $0.016B 0.00
Orgenesis (ORGS) United States $0.016B 0.00
Purple Biotech (PPBT) Israel $0.016B 0.00
Senti Biosciences (SNTI) United States $0.015B 0.00
Talis Biomedical (TLIS) United States $0.015B 0.00
Coeptis Therapeutics Holdings (COEP) United States $0.015B 0.00
IMMURON (IMRN) Australia $0.015B 0.00
Imunon (IMNN) United States $0.015B 0.00
Cocrystal Pharma (COCP) United States $0.015B 0.00
Edesa Biotech (EDSA) Canada $0.014B 0.00
Benitec Biopharma (BNTC) United States $0.014B 0.00
VBI Vaccines (VBIV) United States $0.014B 0.00
Prana Biotechnology (ATHE) Australia $0.014B 0.00
Monopar Therapeutics (MNPR) United States $0.014B 0.00
MIRA Pharmaceuticals (MIRA) United States $0.013B 0.00
Genetic Technologies (GENE) Australia $0.013B 0.00
Telesis Bio (TBIO) United States $0.012B 0.00
Eterna Therapeutics (ERNA) United States $0.012B 0.00
NuCana (NCNA) United Kingdom $0.012B 0.00
ABVC BioPharma (ABVC) United States $0.012B 0.00
Biofrontera (BFRI) United States $0.011B 0.00
BioCardia (BCDA) United States $0.010B 0.00
Elevai Labs (ELAB) United States $0.010B 0.00
Moleculin Biotech (MBRX) United States $0.010B 0.00
Organovo Holdings (ONVO) United States $0.010B 0.00
Virios Therapeutics (VIRI) United States $0.010B 0.00
TFF Pharmaceuticals (TFFP) United States $0.010B 0.00
AEterna Zentaris (AEZS) Canada $0.010B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.010B 0.00
Hepion Pharmaceuticals (HEPA) United States $0.010B 0.00
Adial Pharmaceuticals (ADIL) United States $0.009B 0.00
Cyclerion Therapeutics (CYCN) United States $0.009B 0.00
Biorestorative Therapies (BRTX) United States $0.009B 0.00
Galera Therapeutics (GRTX) United States $0.009B 0.00
Chemomab Therapeutics (CMMB) Israel $0.009B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.008B 0.00
Bionomics (BNOX) Australia $0.008B 0.00
Portage Biotech (PRTG) $0.008B 0.00
Sunshine Biopharma (SBFM) United States $0.008B 0.00
Pulmatrix (PULM) United States $0.008B 0.00
Lixte Biotechnology Holdings (LIXT) United States $0.008B 0.00
Pasithea Therapeutics (KTTA) United States $0.008B 0.00
EFFECTOR Therapeutics (EFTR) United States $0.008B 0.00
Vaccinex (VCNX) United States $0.008B 0.00
Enveric Biosciences (ENVB) United States $0.007B 0.00
Tenax Therapeutics (TENX) United States $0.007B 0.00
AquaBounty Technologies (AQB) United States $0.007B 0.00
Psyence Biomedical (PBM) United States $0.007B 0.00
Creative Medical Technology Holdings (CELZ) United States $0.007B 0.00
Trevena (TRVN) United States $0.007B 0.00
First Wave BioPharma (FWBI) United States $0.007B 0.00
Titan Pharmaceuticals (TTNP) United States $0.007B 0.00
Cadrenal Therapeutics (CVKD) United States $0.007B 0.00
Atrinsic (PTIX) United States $0.006B 0.00
Seelos Therapeutics (SEEL) United States $0.006B 0.00
PaxMedica (PXMD) United States $0.006B 0.00
Sonnet BioTherapeutics Holdings (SONN) United States $0.006B 0.00
Hoth Therapeutics (HOTH) United States $0.006B 0.00
Alzamend Neuro (ALZN) United States $0.006B 0.00
Novogen (KZIA) Australia $0.006B 0.00
Bright Minds Biosciences (DRUG) United States $0.006B 0.00
Silo Pharma (SILO) United States $0.006B 0.00
Ensysce Biosciences (ENSC) United States $0.005B 0.00
GT Biopharma (GTBP) United States $0.005B 0.00
ZyVersa Therapeutics (ZVSA) United States $0.005B 0.00
TRACON Pharmaceuticals (TCON) United States $0.005B 0.00
Mustang Bio (MBIO) United States $0.005B 0.00
GENPREX (GNPX) United States $0.005B 0.00
Synaptogenix (SNPX) United States $0.005B 0.00
Exicure (XCUR) United States $0.005B 0.35
Artelo Biosciences (ARTL) United States $0.005B 0.00
Kintara Therapeutics (KTRA) United States $0.005B 0.00
Biophytis SA (BPTS) France $0.005B 0.00
Cingulate (CING) United States $0.005B 0.00
Tharimmune (THAR) United States $0.005B 0.00
Lipella Pharmaceuticals (LIPO) United States $0.004B 0.00
Longeveron (LGVN) United States $0.004B 0.00
Virpax Pharmaceuticals (VRPX) United States $0.004B 0.00
Soligenix (SNGX) United States $0.004B 0.00
Kineta (KA) United States $0.004B 0.00
NexImmune (NEXI) United States $0.004B 0.00
GeoVax Labs (GOVX) United States $0.004B 0.00
Avalon GloboCare (ALBT) United States $0.004B 0.00
Palisade Bio (PALI) United States $0.004B 0.00
Revelation Biosciences (REVB) United States $0.003B 0.00
Onconetix (ONCO) United States $0.003B 0.00
Dermata Therapeutics (DRMA) United States $0.003B 0.00
CNS Pharmaceuticals (CNSP) United States $0.003B 0.00
Notable Labs (NTBL) United States $0.003B 0.00
ThermoGenesis Holdings (THMO) United States $0.003B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.002B 0.00
Windtree Therapeutics (WINT) United States $0.002B 0.00
Invo BioScience (INVO) United States $0.002B 0.00
180 Life Sciences (ATNF) United States $0.002B 0.00
NeuBase Therapeutics (NBSE) United States $0.002B 0.00
GRI Bio (GRI) United States $0.002B 0.00
Biodexa Pharmaceuticals (BDRX) United Kingdom $0.001B 0.00
Virax Biolabs Group (VRAX) United Kingdom $0.001B 0.00
TC BioPharm (Holdings) (TCBP) United Kingdom $0.001B 0.00
Bone Biologics (BBLG) United States $0.001B 0.00
Scinai Immunotherapeutics (SCNI) Israel $0.001B 0.00
Allarity Therapeutics (ALLR) United States $0.001B 0.00
Aptevo Therapeutics (APVO) United States $0.000B 0.00
Sinovac Biotech (SVA) China $0.000B 0.00
Aceragen (ACGN) United States $0.000B 0.00
Alvotech (ALVO) $0.000B 0.00
ARAVIVE, INC (ARAV) United States $0.000B 0.00
Celyad SA (CYAD) Belgium $0.000B 0.00
LAVA Therapeutics (LVTX) Netherlands $0.000B 0.00
Motif Bio Plc (MTFB) United Kingdom $0.000B 0.00
Mainz Biomed (MYNZ) Germany $0.000B 0.00
PDL BioPharma (PDLI) United States $0.000B 0.00
Pharvaris (PHVS) Netherlands $0.000B 0.00
Tiziana Life Sciences (TLSA) United Kingdom $0.000B 0.00
VectivBio Holding AG (VECT) Switzerland $0.000B 0.00
Clovis Oncology (CLVSQ) United States $0.000B 0.00